| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |